Research ArticleBRAIN
Prognostic Factors in Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma Treated with Selective Intra-arterial Chemotherapy
Kira L. Chow, Y. Pierre Gobin, Timothy Cloughesy, James W. Sayre, J. Pablo Villablanca and Fernando Viñuela
American Journal of Neuroradiology March 2000, 21 (3) 471-478;
Kira L. Chow
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
Y. Pierre Gobin
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
Timothy Cloughesy
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
James W. Sayre
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
J. Pablo Villablanca
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
Fernando Viñuela
aFrom the University of California in Los Angeles Medical Center, B7–146A CHS 172115, 10833 Le Conte Ave, Los Angeles, CA 90095–1721.
References
- ↵Salcman M. Glioblastoma and malignant astrocytoma. In: Kaye A, Laws E, Jr. eds. Brain Tumors: An Encyclopedic Approach. Edinburgh: Churchill Livingstone; 1995; 449–477
- ↵Shugg D, Allen B, Blizzard L, Dwyer T. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 1994;59:765-770
- Greig N, Ries L, Yancik R, Rapoport S. Increasing annual incidence of primary malignant brain tumours in the elderly. J Natl Cancer Inst 1990;82:1621-1624
- Ahlbom A, Rodvall Y. Brain tumour trends. Lancet 1989;2:1272
- ↵Wurschmidt F, Bunemann H, Heilmann HP. Prognostic factors in high-grade malignant glioma: a multivariate analysis of 76 cases with postoperative radiotherapy. Strahlenther Onkol 1995;171:315-321
- ↵
- ↵Fine H, Dear K, Loeffler J, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597
- ↵Sipos E, Brem H. New delivery systems for brain tumor therapy. Neurologic Clinics 1995;13:813-825
- ↵Stewart DJ, Belanger JM, Grahovac A, et al. Phase I study of intracarotid administration of carboplatin. Neurosurgery 1992;30:512-517
- Dropcho EJ, Rosenfeld SS, Morawetz RB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. J Clin Oncol 1992;10:452-458
- ↵Chang CH, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983;52:997-1007
- ↵Mahaley MJ, Hipp S, EJ D, et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 1989;70:371-378
- Neuwelt E, Howieson J, Frenkel E, et al. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 1986;19:573-582
- ↵Rajan B, Ross G, Lim CC, et al. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer1994:1809-1815
- ↵Salminen E, Nuutinen JM, Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer1996:1918-1923
- ↵
- Watne K, Hannisdal E, Nome O, et al. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. Neurosurgery 1992;30:223-227
- ↵Inamura R, Nomura R, Bartus RT, Black KL. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. J Neurosurg 1994;81:752-758
- ↵
- ↵Pasqualin A, Barone G, Cioffi F, Rosta L, Scienza R, Da Pian R. The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations. Neurosurgery 1991;28:370-379
- ↵Kirby S, Brothers M, Irish W, et al. Evaluating glioma therapies: modeling treatments and predicting outcomes. J Natl Cancer Inst 1995;87:1884-1888
- ↵Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 1997;15:3129-3140
- ↵Gehan E, Walker M. Prognostic factors for patients with brain tumors. Nat Cancer Inst Monogr 1977;46:189-195
- ↵Green S, Byar D, Walker M, et al. Comparison of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983;67:121-132
- ↵
- Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 1983;52:550-554
- ↵Kowalczuk A, Macdonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997;41:1028-1038
- ↵
- ↵MacDonald DR, Cascino TL, Schold SCJ, Cairncross G. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280
- ↵Harsh G. Management of recurrent gliomas and meningiomas. In: Kaye A, Laws E, eds. Brain Tumors: An Encyclopedic Approach. Edinburgh: Churchill Livingstone; 1995:413–428
- Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 1994;35:378-388
- ↵Burger P, Heinz E, Shibata T, et al. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurgery 1988;68:698-704
- ↵
- Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 1988;6:338-343
- Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 1994;35:378-388
- ↵Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 1976;23:440-453
- ↵Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;333:1182-1186
- ↵Russel DC, Rubinstein LJ. Pathology of Tumors of the Nervous System.. 5th ed. London: Arnold; 1989
- ↵Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-372
- ↵Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88:513-520
- ↵Jensen RL. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 1998;49:189-196
- ↵Korkolopoulou P, Christodoulou P, Kouzelis K, et al. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 1997;75:1269-1278
- ↵
- Paulus W, Peiffer J. Intratumoral histologic heterogeneity of gliomas. Cancer 1989;64:2014-2023
- ↵Kadota T, Nakagawa H, Kuroda C. Malignant glioma: evaluation with 3D time-of-flight MR angiography. Acta Radiol 1998;39:227-232
- Less JR, Skallak TC, Sevick EM, Jain RK. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Research 1991;51:265-273
- Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Research 1994;54:4564-4568
- ↵Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 1992;76:792-798
In this issue
Advertisement
Prognostic Factors in Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma Treated with Selective Intra-arterial Chemotherapy
Kira L. Chow, Y. Pierre Gobin, Timothy Cloughesy, James W. Sayre, J. Pablo Villablanca, Fernando Viñuela
American Journal of Neuroradiology Mar 2000, 21 (3) 471-478;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Super-Resolution Ultrasound Bubble Tracking for Preclinical and Clinical Multiparametric Tumor Characterization
- Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review
- Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement